This is an excerpt from the About section of one of their latest...

First 14 Last

Share
Profile

Follow
Oupa

351 Posts.

51

01/03/21

12:34

Post #: 51416616
Share

Originally posted by riskyrider: ↑

Factually wrong Hopper still has milestones left so has a larger interest in KZA than you. Also the drug had finsished Phase I not in Phase I.
You really should remove staements that are false.

Also maybe don't make defamatory comments about powerful people online. Just a thought.

I'm hoping James makes it but there is no guarantee.

Also Hopper is a bio bilionare and has developed many drugs. Car T in GBM is a real threat to GDC it is in many cases curative on its own and many cancers its a first line therapy now even in Australia. If you got a cancer right now you'd be looking for an in to a trial in Car T.

It's in direct competition and the man who sold us GDC is backing it over GDC. Its worth knowing and I'm raising it here to share. Do what you want with it but it is real it is correct and don't counter it with lies and defamatory statements. If you are in a strong position why would you act weak.

Not saying sell I'm not selling its just the reality of the landscape. There is no moat around this company speed is everything.

Good luck.

Expand

This is an excerpt from the About section of one of their latest ASX announcements...

”Chimeric Therapeutics is currently in a phase 1 clinical trial for its lead asset, CLTX-CAR T. “

It clearly states in the trial.

KZA Price at posting: $1.31 Sentiment: Hold Disclosure: Held
8 Upvote

1 Great analysis

Reply

Top Stories

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

WGX

Westgold sets its sights on top five producer status through merger with Karora

GRX

GreenX picks up prospective copper project in Germany

Is oil undervalued?

VMT

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

MGU

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

NXG

Cost blow-out for Rook I uranium project sees share plummet for NexGen

VMS

Venture to sniff out high-grade REE targets at Jupiter project, WA

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

DVP

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

There are more pages in this discussion • 17 more messages in this thread...

First 14 Last

Add KZA (ASX) to my watchlist

This is an excerpt from the About section of one of their latest...

Top Stories

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Westgold sets its sights on top five producer status through merger with Karora

GreenX picks up prospective copper project in Germany

Is oil undervalued?

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Venture to sniff out high-grade REE targets at Jupiter project, WA

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Featured News